R. Dansey

New England Journal of Medicine · 2010–2014

A researcher in the Science corpus: 9 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Papers from R. Dansey's perspective

Ordered by how strongly the researchers R. Dansey trusts endorse each paper. Same corpus, a different order for every researcher.

  1. American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. (Journal of Clinical Oncology)
  2. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. (Journal of oral and maxillofacial surgery)
  3. A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma. (Journal of the National Cancer Institute)
  4. Denosumab in postmenopausal women with low bone mineral density. (New England Journal of Medicine)
  5. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. (Journal of oral and maxillofacial surgery)
  6. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update. (Journal of oral and maxillofacial surgery)
  7. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. (Journal of Clinical Oncology)
  8. Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors. (Journal of Clinical Oncology)
  9. Mechanisms of bone metastasis. (Discover medicine)
  10. Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer. (Journal of the National Cancer Institute)

Their papers